United States v. Tulloch

380 F.3d 8, 2004 U.S. App. LEXIS 16618, 2004 WL 1797466
CourtCourt of Appeals for the First Circuit
DecidedAugust 12, 2004
Docket02-1749, 02-2410
StatusPublished
Cited by27 cases

This text of 380 F.3d 8 (United States v. Tulloch) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Tulloch, 380 F.3d 8, 2004 U.S. App. LEXIS 16618, 2004 WL 1797466 (1st Cir. 2004).

Opinion

*10 PER CURIAM.

These appeals raise ongoing issues pertaining to supervised release conditions that were first addressed in this circuit in United States v. Melendez-Santana, 353 F.3d 93 (1st Cir.2003). In this opinion, we hold that a mandatory drug testing condition may be included in the written sentencing judgment without having been mentioned at sentencing. We also hold that the standard supervised release conditions set out in the United States Sentencing Guidelines may be adopted by reference at the sentencing hearing.

I. Background

In separate criminal proceedings, Higinio Alejandro-Castillo (“Castillo”) and Mesfin Haile Tulloch (“Tulloch”) pled guilty to entering or attempting to reenter the United States in violation of 8 U.S.C. § 1326(a) and (b)(2). They were sentenced to terms of imprisonment and three-year terms of supervised release. On appeal, each of them contends that the sentencing court improperly delegated sentencing authority to the probation officer by allowing the officer to determine how many drug tests were required during their terms on supervision. See Melendez-Santana, 353 F.3d at 106 (holding that 18 U.S.C. § 3583(d) “requires courts to determine the maximum number of drug tests to be performed beyond the statutory minimum of three”). They also contend that the court included supervised release conditions in the written judgments that were not mentioned specifically at the sentencing hearings, in violation of their right to be present at sentencing. See id. at 99-100 (explaining this constitutional and statutory right). To the extent appellants could have raised their present claims of error at their respective sentencing proceedings, but did not, we review those claims for plain error; otherwise, our review is for abuse of discretion. Id. at 102, 107 n. 14.

II. The Claims

A. Delegation

At Castillo’s sentencing hearing, the court made no mention of drug testing. Its written judgment included a supervised release condition requiring him to submit to one drug test within 15 days of release from imprisonment “and thereafter as required by the U.S. Probation Officer.” In Tulloch’s case, the court ordered him at sentencing to submit to three “periodic drug tests,” but made no reference to the probation officer. Its written judgment ordered one drug test within the first 15 days after release and “at least two periodic drug tests thereafter, as directed by the probation officer.”

Appellants assert that the written conditions improperly delegated each court’s sentencing authority by allowing the probation officer to determine the maximum number of drug tests. We agree. In each case, the sentencing court essentially “vest[ed] the probation officer with the discretion to order an unlimited number of drug tests,” which it could not do. Melendez-Santana, 353 F.3d at 103. On remand, we direct the respective courts to strike the improper delegation from their written judgments. 1

Tulloch makes an additional delegation claim. He contends that the court impermissibly allowed the probation officer to determine the timing of the drug tests. We reject this claim. As our previous cases indicate, the scheduling of tests *11 to ensure compliance with supervised release conditions is an administrative task that probation officers lawfully may perform. See United States v. York, 357 F.3d 14, 21-22 (1st Cir.2004) (sustaining condition ordering “periodic” polygraph examinations); see also Melendez-Santana, 353 F.3d at 103 (expressing doubt that Congress would expect courts to become involved in scheduling drug tests) (dictum).

B. Right to be Present

Both appellants assert a violation of their right to be present at sentencing. Castillo complains that the drug testing condition was never mentioned at his sentencing hearing. 2 Tulloch objects to the standard conditions contained in his written judgment on the ground that the district court had only generally referenced them at sentencing. 3 To succeed on appeal, appellants must show that the challenged written conditions “conflict in a material way” with their oral sentences. Melendez-Santana, 353 F.3d at 100. We conclude that there is no material conflict between appellants’ oral sentences imposing terms of supervised release and the written conditions they challenge. We turn first to Castillo’s claim.

1. Castillo

In theory, requiring repeated drug testing could conceivably inflict a significant burden on supervisees. Therefore, if a drug testing condition is not mentioned at sentencing, defendants might reasonably claim that their right to be present has been violated. Context is critical, however. In this case, as our discussion below indicates, the written judgment simply imposes the same burden on Castillo as his oral sentence directing him to serve a supervised release term. Therefore, there is no material conflict between his written and oral sentences. See id., 353 F.3d at 100 (suggesting that a material conflict exists where the written sentence imposes a “potentially significant new burden on the Defendant”).

Castillo was sentenced in 2002, and drug testing has been a mandatory condition of supervision since 1994. In that year, 18 U.S.C. § 3583(d) was amended to require drug testing as an explicit condition for defendants on supervised release. 18 U.S.C.A. § 3583(d) (2000) (historical and statutory notes); Melendez-Santana, 353 F.3d at 104. In 1997, the United States Sentencing Guidelines were amended accordingly, referencing the mandatory drug testing requirement for the first time. U.S. Sentencing Guidelines Manual § 5D1.3(a)(4) (1997); see 18 U.S.C.A. Fed. Sent. Guidelines (2004 Supp. Pamphlet) (historical notes, 1997 Amendments); United States v. Jackson, 189 F.3d 820, 822 (9th Cir.1999) (noting that, prior to the 1997 amendment, courts had discretion to impose a drug testing condition under § 5D1.3(b)). Since their amendment, § 3583(d) and Guideline § 5D1.3(a)(4) have *12 provided defendants facing supervised release terras with constructive notice that they will be required to undergo drug testing during their supervised release terms. See United States v. Paul,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Maiorana
Second Circuit, 2025
United States v. Rabb
5 F.4th 95 (First Circuit, 2021)
United States v. Nardozzi
2 F.4th 2 (First Circuit, 2021)
United States v. Miller
978 F.3d 746 (Tenth Circuit, 2020)
United States v. Rosie Diggles
957 F.3d 551 (Fifth Circuit, 2020)
United States v. John Cabello
916 F.3d 543 (Fifth Circuit, 2019)
United States v. Cueto-Nunez
869 F.3d 31 (First Circuit, 2017)
United States v. Domingo Blount
777 F.3d 368 (Seventh Circuit, 2015)
United States v. David Thompson
Seventh Circuit, 2015
United States v. Van Thi Nguyen
618 F.3d 72 (First Circuit, 2010)
United States v. Paul
542 F.3d 596 (Seventh Circuit, 2008)
United States v. Paul, John E.
Seventh Circuit, 2008
United States v. Sepulveda Contreras
466 F.3d 166 (First Circuit, 2006)
United States v. Ortiz-Torres
449 F.3d 61 (First Circuit, 2006)
United States v. Santos-Rios
151 F. App'x 2 (First Circuit, 2005)
United States v. Vega-Ortiz
425 F.3d 20 (First Circuit, 2005)
United States v. Gambaro
First Circuit, 2005
United States v. Antonio D. Stephens
424 F.3d 876 (Ninth Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
380 F.3d 8, 2004 U.S. App. LEXIS 16618, 2004 WL 1797466, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-tulloch-ca1-2004.